R01 CA207468/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2018	2
2019	3
2020	1
2021	4
2022	2
2024	0

1

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update.

Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A. Bohlius J, et al. J Clin Oncol. 2019 May 20;37(15):1336-1351. doi: 10.1200/JCO.18.02142. Epub 2019 Apr 10. J Clin Oncol. 2019. PMID: 30969847 Free article.

2

Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update.

Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A. Bohlius J, et al. Blood Adv. 2019 Apr 23;3(8):1197-1210. doi: 10.1182/bloodadvances.2018030387. Blood Adv. 2019. PMID: 30971397 Free PMC article. Review.

3

Factors Likely to Affect the Uptake of Genomic Approaches to Cancer Screening in Primary Care: A Scoping Review.

Davis KV, Hallman MH, DiCarlo M, Wambua SM, Jaffe RL, Welsh AW, Kerber C, Yang H, Chambers CV, Myers RE. Davis KV, et al. J Pers Med. 2022 Dec 10;12(12):2044. doi: 10.3390/jpm12122044. J Pers Med. 2022. PMID: 36556264 Free PMC article. Review.

4

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer.

Gerratana L, Davis AA, Zhang Q, Basile D, Rossi G, Strickland K, Franzoni A, Allegri L, Mu Z, Zhang Y, Flaum LE, Damante G, Gradishar WJ, Platanias LC, Behdad A, Yang H, Puglisi F, Cristofanilli M. Gerratana L, et al. JCO Precis Oncol. 2021 Jun 8;5:943-952. doi: 10.1200/PO.20.00345. eCollection 2021 Jun. JCO Precis Oncol. 2021. PMID: 34136741 Free PMC article.

5

DNA Methylation of Telomere-Related Genes and Cancer Risk.

Joyce BT, Zheng Y, Nannini D, Zhang Z, Liu L, Gao T, Kocherginsky M, Murphy R, Yang H, Achenbach CJ, Roberts LR, Hoxha M, Shen J, Vokonas P, Schwartz J, Baccarelli A, Hou L. Joyce BT, et al. Cancer Prev Res (Phila). 2018 Aug;11(8):511-522. doi: 10.1158/1940-6207.CAPR-17-0413. Epub 2018 Jun 12. Cancer Prev Res (Phila). 2018. PMID: 29895583 Free PMC article.

6

Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer.

Wang C, Zhang Z, Chong W, Luo R, Myers RE, Gu J, Lin J, Wei Q, Li B, Rebbeck TR, Lu-Yao G, Kelly WK, Yang H. Wang C, et al. Cancers (Basel). 2021 Jan 13;13(2):268. doi: 10.3390/cancers13020268. Cancers (Basel). 2021. PMID: 33450815 Free PMC article.

7

Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients.

Chong W, Zhang Z, Luo R, Gu J, Lin J, Wei Q, Li B, Myers R, Lu-Yao G, Kelly WK, Wang C, Yang H. Chong W, et al. BMC Cancer. 2021 Jun 2;21(1):655. doi: 10.1186/s12885-021-08405-3. BMC Cancer. 2021. PMID: 34078304 Free PMC article.

8

Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer.

Luo R, Chong W, Wei Q, Zhang Z, Wang C, Ye Z, Abu-Khalaf MM, Silver DP, Stapp RT, Jiang W, Myers RE, Li B, Cristofanilli M, Yang H. Luo R, et al. NPJ Breast Cancer. 2021 Jun 1;7(1):72. doi: 10.1038/s41523-021-00278-w. NPJ Breast Cancer. 2021. PMID: 34075047 Free PMC article.

9

Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.

Ye Z, Wang C, Wan S, Mu Z, Zhang Z, Abu-Khalaf MM, Fellin FM, Silver DP, Neupane M, Jaslow RJ, Bhattacharya S, Tsangaris TN, Chervoneva I, Berger A, Austin L, Palazzo JP, Myers RE, Pancholy N, Toorkey D, Yao K, Krall M, Li X, Chen X, Fu X, Xing J, Hou L, Wei Q, Li B, Cristofanilli M, Yang H. Ye Z, et al. Eur J Cancer. 2019 Jan;106:133-143. doi: 10.1016/j.ejca.2018.10.012. Epub 2018 Dec 4. Eur J Cancer. 2019. PMID: 30528798 Free PMC article.

10

Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.

Abu-Khalaf M, Wang C, Zhang Z, Luo R, Chong W, Silver DP, Fellin F, Jaslow R, Lopez A, Cescon T, Jiang W, Myers R, Wei Q, Li B, Cristofanilli M, Yang H. Abu-Khalaf M, et al. Cancers (Basel). 2022 Jun 10;14(12):2872. doi: 10.3390/cancers14122872. Cancers (Basel). 2022. PMID: 35740538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year